Tatyana I. Romanova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tatyana I. Romanova has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Irina N. Grigor’eVa
Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences
7 shared publications - Tatyana S. Suvorova
Novosibirsk State Medical University
2 shared publications - Aleksey V. Kuznetsov
Federal State Budgetary Educational Institution of Higher Education, Novosibirsk State Medical University, Ministry of Health of Russia, 52 Krasniy Prospekt, Novosibirsk 630091, Russia
1 shared publication D. L. Nepomnyashchikh
Novosibirsk State Medical University
1 shared publication- Diana V. Denisova
Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences
1 shared publication E. A. Belyaevskaya
Research Institute of Internal and Preventive Medicine – Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences
1 shared publication
Latest Publications
- Open Access
- 4 July 2025
- Published by The Institute of Internal and Preventive Medicine in Ateroscleroz
- Vol. 21 (2) , 148-155
Сomorbidity of obesity and dyspepsia in residents of Novosibirsk aged 35–54 years
The sensory and motor functions of the stomach, including gastric emptying and accommodation, leading to dyspepsia (D), significantly affect energy expenditure, and obesity is characterized by an energy imbalance. However, the data on the association of obesity and FD are heterogeneous. Aim: to assess the prevalence of obesity and D, its types, and to identify a possible association of D with obesity in a population sample (PS) aged 35–54 years. Material and methods. During 2023–2025, a random representative sample of 35–54-year-olds from one of the districts of the city is being surveyed on the basis of NIITPM. Novosibirsk. As part of the gastroenterological fragment, the PS examination of 192 persons (92 men and 100 women) included: gender, age, BMI, filling in the mFSSG D scale (a total score of 6 points corresponded to D). The results are presented as Me [Q25; Q75]. Results. The average age in PS in people with/without D, in men and women did not differ. The prevalence of D in PS (n = 192) was 26.04 % (n = 50), in women – 64.00 %, in men – 36.00 % (p < 0.05). The prevalence of two types of FD: epigastric pain syndrome (EPS) is 24.00 %, and postprandial distress syndrome (PРDS) is 76.00 % (p < 0.05). The prevalence of obesity in the PS of people without D was 24.82%, with D – 32.00 % (p > 0.05). The BMI in individuals with PРDS – 27.54 [23.78; 32.96] kg/m2 exceeded the BMI in individuals with EPS – 23.56 [22.19; 27.02] kg/m2 (p < 0.05). Obesity is associated with the presence of PРDS (rSpearmen = +0.48, p < 0.05). In PS, no association was found between the presence of D and obesity, but among people over 53 years of age with obesity, D was observed 11.2 times more often than in people with normal body mass (p = 0.037). Conclusions. In PS in Novosibirsk, 35–54 years old, D is characterized by a high prevalence, and in women it is 1.78 times higher than in men; PPDS dominates in the D patients. The prevalence of obesity in PS in people with and without D did not differ, however, an association of obesity with D was found in people over 53 years and in people with PPDS.
- 4 July 2025
- Published by The Institute of Internal and Preventive Medicine in Ateroscleroz
- Vol. 21 (2) , 148-155
Open AccessСomorbidity of obesity and dyspepsia in residents of Novosibirsk aged 35–54 years
The sensory and motor functions of the stomach, including gastric emptying and accommodation, leading to dyspepsia (D), significantly affect energy expenditure, and obesity is characterized by an energy imbalance. However, the data on the association of obesity and FD are heterogeneous. Aim: to assess the prevalence of obesity and D, its types, and to identify a possible association of D with obesity in a population sample (PS) aged 35–54 years. Material and methods. During 2023–2025, a random representative sample of 35–54-year-olds from one of the districts of the city is being surveyed on the basis of NIITPM. Novosibirsk. As part of the gastroenterological fragment, the PS examination of 192 persons (92 men and 100 women) included: gender, age, BMI, filling in the mFSSG D scale (a total score of 6 points corresponded to D). The results are presented as Me [Q25; Q75]. Results. The average age in PS in people with/without D, in men and women did not differ. The prevalence of D in PS (n = 192) was 26.04 % (n = 50), in women – 64.00 %, in men – 36.00 % (p < 0.05). The prevalence of two types of FD: epigastric pain syndrome (EPS) is 24.00 %, and postprandial distress syndrome (PРDS) is 76.00 % (p < 0.05). The prevalence of obesity in the PS of people without D was 24.82%, with D – 32.00 % (p > 0.05). The BMI in individuals with PРDS – 27.54 [23.78; 32.96] kg/m2 exceeded the BMI in individuals with EPS – 23.56 [22.19; 27.02] kg/m2 (p < 0.05). Obesity is associated with the presence of PРDS (rSpearmen = +0.48, p < 0.05). In PS, no association was found between the presence of D and obesity, but among people over 53 years of age with obesity, D was observed 11.2 times more often than in people with normal body mass (p = 0.037). Conclusions. In PS in Novosibirsk, 35–54 years old, D is characterized by a high prevalence, and in women it is 1.78 times higher than in men; PPDS dominates in the D patients. The prevalence of obesity in PS in people with and without D did not differ, however, an association of obesity with D was found in people over 53 years and in people with PPDS.
- 9 November 2024
- Published by Alfmed LLC in Medical alphabet
- No. 26,p. 19-23
Metformin and intestinal microbiota
A number of human and animal studies have demonstrated that the hyperglycemia-lowering effects of metformin may result from modulation of the gut microbiota population. Metformin changes the Firmicutes/Bacteroidetes ratio and enhances the growth of some bacteria, such as Akkermansia muciniphila, Escherichia spp. or Lactobacillus and reduce the levels of others such as Intestinibacter. Moreover, in the intestine, metformin not only improves glucose absorption, but also promotes the production of short-chain fatty acids (SCFAs), regulates the secretion of the glucose-lowering hormone glucagon-like peptide 1 (GLP‑1) and other intestinal peptides, inhibits the Farnesoid-X-receptor (FXR) and resorption of the bile acid pool, and may reduce intestinal permeability barrier by increasing the expression of mucin and tight junction proteins, modulates the immune response, has an anti-inflammatory effect, etc. Thus, research results indicate that the intestinal microbiota is involved not only in the hypoglycemic effect of metformin in diabetes mellitus type 2, but also in the implementation of its numerous pleiotropic effects.
- 9 November 2024
- Published by Alfmed LLC in Medical alphabet
- No. 26,p. 19-23
Metformin and intestinal microbiota
A number of human and animal studies have demonstrated that the hyperglycemia-lowering effects of metformin may result from modulation of the gut microbiota population. Metformin changes the Firmicutes/Bacteroidetes ratio and enhances the growth of some bacteria, such as Akkermansia muciniphila, Escherichia spp. or Lactobacillus and reduce the levels of others such as Intestinibacter. Moreover, in the intestine, metformin not only improves glucose absorption, but also promotes the production of short-chain fatty acids (SCFAs), regulates the secretion of the glucose-lowering hormone glucagon-like peptide 1 (GLP‑1) and other intestinal peptides, inhibits the Farnesoid-X-receptor (FXR) and resorption of the bile acid pool, and may reduce intestinal permeability barrier by increasing the expression of mucin and tight junction proteins, modulates the immune response, has an anti-inflammatory effect, etc. Thus, research results indicate that the intestinal microbiota is involved not only in the hypoglycemic effect of metformin in diabetes mellitus type 2, but also in the implementation of its numerous pleiotropic effects.
- Open Access
- 23 April 2023
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 33 (1) , 7-14
Physical Activity and Gallstone Disease
Аim: to present data of Russian and foreign studies about association between physical activity (PA) and gallstone disease (GSD).Key point. A low PA level is one of the four major risk factors for chronic non-infectiuos diseases. The frequency of low PA in men and women of the Russian Federation (according to the medical examination in 2016) is 19 %. The global prevalence of GSD is up to 20 % among adults. Many systematic reviews and meta-analyses have confirmed an inverse association between GSD and PA in the world, regardless of potential risk factors for GSD, with a clear dose-dependent effect — the relative risk (RR) of GSD was 0.87 (95 % CI 0.83–0.92) per 20 metabolic equivalents (MET) of PA per week. According to our results of an epidemiological survey in the framework of the WHO MONICA program in Novosibirsk (n = 870) among women aged 25–64 with low total PA (less than 800 MET/min/week), as well as with the first class of PA in leisure-time, GSD occurred much more often (class 1 — 33 %, classes 2–4 — 8.7–11.0 %, p < 0.01). PA favorably affects almost all mechanisms of gallstone formation: improves cholesterol metabolism in bile, increases serum HDL cholesterol, bile acid synthesis, stimulates the release of cholecystokinin, reduces mucin hypersecretion, increases the diversity and richness of the intestinal microbiota. Daily PA serves as a preventive measure for GSD: the risk of GSD is reduced by 66 % (95 % CI 0.18–0.86).Conclusion. EASL has recognized PA as a protective agent against gallstone formation.
- 23 April 2023
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 33 (1) , 7-14
Open AccessPhysical Activity and Gallstone Disease
Аim: to present data of Russian and foreign studies about association between physical activity (PA) and gallstone disease (GSD).Key point. A low PA level is one of the four major risk factors for chronic non-infectiuos diseases. The frequency of low PA in men and women of the Russian Federation (according to the medical examination in 2016) is 19 %. The global prevalence of GSD is up to 20 % among adults. Many systematic reviews and meta-analyses have confirmed an inverse association between GSD and PA in the world, regardless of potential risk factors for GSD, with a clear dose-dependent effect — the relative risk (RR) of GSD was 0.87 (95 % CI 0.83–0.92) per 20 metabolic equivalents (MET) of PA per week. According to our results of an epidemiological survey in the framework of the WHO MONICA program in Novosibirsk (n = 870) among women aged 25–64 with low total PA (less than 800 MET/min/week), as well as with the first class of PA in leisure-time, GSD occurred much more often (class 1 — 33 %, classes 2–4 — 8.7–11.0 %, p < 0.01). PA favorably affects almost all mechanisms of gallstone formation: improves cholesterol metabolism in bile, increases serum HDL cholesterol, bile acid synthesis, stimulates the release of cholecystokinin, reduces mucin hypersecretion, increases the diversity and richness of the intestinal microbiota. Daily PA serves as a preventive measure for GSD: the risk of GSD is reduced by 66 % (95 % CI 0.18–0.86).Conclusion. EASL has recognized PA as a protective agent against gallstone formation.
- Open Access
- 12 April 2021
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (4) , 294
Gut Microbiome in a Russian Cohort of Pre- and Post-Cholecystectomy Female Patients
The last decade saw extensive studies of the human gut microbiome and its relationship to specific diseases, including gallstone disease (GSD). The information about the gut microbiome in GSD-afflicted Russian patients is scarce, despite the increasing GSD incidence worldwide. Although the gut microbiota was described in some GSD cohorts, little is known regarding the gut microbiome before and after cholecystectomy (CCE). By using Illumina MiSeq sequencing of 16S rRNA gene amplicons, we inventoried the fecal bacteriobiome composition and structure in GSD-afflicted females, seeking to reveal associations with age, BMI and some blood biochemistry. Overall, 11 bacterial phyla were identified, containing 916 operational taxonomic units (OTUs). The fecal bacteriobiome was dominated by Firmicutes (66% relative abundance), followed by Bacteroidetes (19%), Actinobacteria (8%) and Proteobacteria (4%) phyla. Most (97%) of the OTUs were minor or rare species with ≤1% relative abundance. Prevotella and Enterocossus were linked to blood bilirubin. Some taxa had differential pre- and post-CCE abundance, despite the very short time (1–3 days) elapsed after CCE. The detailed description of the bacteriobiome in pre-CCE female patients suggests bacterial foci for further research to elucidate the gut microbiota and GSD relationship and has potentially important biological and medical implications regarding gut bacteria involvement in the increased GSD incidence rate in females.
- 12 April 2021
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (4) , 294
Open AccessGut Microbiome in a Russian Cohort of Pre- and Post-Cholecystectomy Female Patients
The last decade saw extensive studies of the human gut microbiome and its relationship to specific diseases, including gallstone disease (GSD). The information about the gut microbiome in GSD-afflicted Russian patients is scarce, despite the increasing GSD incidence worldwide. Although the gut microbiota was described in some GSD cohorts, little is known regarding the gut microbiome before and after cholecystectomy (CCE). By using Illumina MiSeq sequencing of 16S rRNA gene amplicons, we inventoried the fecal bacteriobiome composition and structure in GSD-afflicted females, seeking to reveal associations with age, BMI and some blood biochemistry. Overall, 11 bacterial phyla were identified, containing 916 operational taxonomic units (OTUs). The fecal bacteriobiome was dominated by Firmicutes (66% relative abundance), followed by Bacteroidetes (19%), Actinobacteria (8%) and Proteobacteria (4%) phyla. Most (97%) of the OTUs were minor or rare species with ≤1% relative abundance. Prevotella and Enterocossus were linked to blood bilirubin. Some taxa had differential pre- and post-CCE abundance, despite the very short time (1–3 days) elapsed after CCE. The detailed description of the bacteriobiome in pre-CCE female patients suggests bacterial foci for further research to elucidate the gut microbiota and GSD relationship and has potentially important biological and medical implications regarding gut bacteria involvement in the increased GSD incidence rate in females.
- Open Access
- 11 July 2020
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 25 (6) , 3823
Prevalence of hypertension, levels of lipids and blood glucose in patients with acute pancreatitis, chronic pancreatitis and pancreatic cancer
Aim. To determine the prevalence of hypertension (HTN) in patients with acute pancreatitis (AP), chronic pancreatitis (CP), pancreatic cancer (PC) and establish associations of HTN with other risk factors (obesity, dyslipidemia (DLP), plasma glucose ≥7,0 mmol/l, smoking, alcohol consumption).Material and methods. This observational multicenter clinical cross-sectional uncontrolled study included 44 patients with AP, 97 patients with CP and 45 patients with PC. The groups were comparable by sex and age. The HTN was diagnosed according to the criteria of Russian Society of Cardiology (2020).Results. HTN was much more common in patients with PC (55,6%) than in patients with AP (25,0%) (χ 2 =8,6, p=0,003). In patients with CP, the prevalence of HTN (39,2%) did not differ from those with AP or PC. Among patients with AP and HTN, higher levels of triglycerides (TG) (U=88,0, p=0,010) and glucose (U=89,5, p=0,011) than in non-HTN patients with AP were determined. In HTN patients with CP, glucose ≥7,0 mmol/l was recorded 3 times more often than in non-HTN patients with CP (χ 2 =16,2, p=0,000). In patients with PC and HTN, a higher mean body mass index (BMI) (F=7,8, p=0,008) and less common normal body weight than in non-HTN patients with PC (28,0 and 65,0%, χ 2 =6,2, p=0,013) was revealed. In patients with CP, increased glucose levels by 1 mmol/l (Exp (B)=1,933, 95% confidence interval (CI) 1,350-2,767, p=0,000) or BMI by 1 kg/m2 (Exp (B)=1,224, 95% CI 1,085-1,380, p=0,001) raised the probability of HTN; in patients with PC, increased BMI by 1 kg/ m2 (Exp (B)=1,394, 95% CI 1,057-1,840, p=0,019) or age by 1 year (Exp (B)=1,251, 95% CI 1,052-1,489, p=0,011) raised the probability of HTN.Conclusion. HTN was more often observed in patients with PC than in those with AP. In patients with CP, the prevalence of HTN did not differ from those with AP or PC. HTN was a cofactor to other metabolic risk factors (glucose ≥7,0 mmol/l, obesity) in patients with AP or CP; behavioral risk factors, on the contrary, were less common in HTN patients with AP or CP. In patients with CP, there was a direct association of HTN with glucose levels or BMI, and in patients with PC — HTN with BMI or age.
- 11 July 2020
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 25 (6) , 3823
Open AccessPrevalence of hypertension, levels of lipids and blood glucose in patients with acute pancreatitis, chronic pancreatitis and pancreatic cancer
Aim. To determine the prevalence of hypertension (HTN) in patients with acute pancreatitis (AP), chronic pancreatitis (CP), pancreatic cancer (PC) and establish associations of HTN with other risk factors (obesity, dyslipidemia (DLP), plasma glucose ≥7,0 mmol/l, smoking, alcohol consumption).Material and methods. This observational multicenter clinical cross-sectional uncontrolled study included 44 patients with AP, 97 patients with CP and 45 patients with PC. The groups were comparable by sex and age. The HTN was diagnosed according to the criteria of Russian Society of Cardiology (2020).Results. HTN was much more common in patients with PC (55,6%) than in patients with AP (25,0%) (χ 2 =8,6, p=0,003). In patients with CP, the prevalence of HTN (39,2%) did not differ from those with AP or PC. Among patients with AP and HTN, higher levels of triglycerides (TG) (U=88,0, p=0,010) and glucose (U=89,5, p=0,011) than in non-HTN patients with AP were determined. In HTN patients with CP, glucose ≥7,0 mmol/l was recorded 3 times more often than in non-HTN patients with CP (χ 2 =16,2, p=0,000). In patients with PC and HTN, a higher mean body mass index (BMI) (F=7,8, p=0,008) and less common normal body weight than in non-HTN patients with PC (28,0 and 65,0%, χ 2 =6,2, p=0,013) was revealed. In patients with CP, increased glucose levels by 1 mmol/l (Exp (B)=1,933, 95% confidence interval (CI) 1,350-2,767, p=0,000) or BMI by 1 kg/m2 (Exp (B)=1,224, 95% CI 1,085-1,380, p=0,001) raised the probability of HTN; in patients with PC, increased BMI by 1 kg/ m2 (Exp (B)=1,394, 95% CI 1,057-1,840, p=0,019) or age by 1 year (Exp (B)=1,251, 95% CI 1,052-1,489, p=0,011) raised the probability of HTN.Conclusion. HTN was more often observed in patients with PC than in those with AP. In patients with CP, the prevalence of HTN did not differ from those with AP or PC. HTN was a cofactor to other metabolic risk factors (glucose ≥7,0 mmol/l, obesity) in patients with AP or CP; behavioral risk factors, on the contrary, were less common in HTN patients with AP or CP. In patients with CP, there was a direct association of HTN with glucose levels or BMI, and in patients with PC — HTN with BMI or age.
- Open Access
- 2 June 2020
- Published by MDPI AG in Microorganisms
- Vol. 8 (6) , 835
Gallstone Disease and Microbiome
Gallstone disease (GSD) has, for many years, remained a high-cost, socially significant public health problem. Over the past decade, a number of studies have been carried out—both in humans and in animal models—confirming the role of the microbiota in various sections of the gastrointestinal tract as a new link in the etiopathogenesis of GSD. The microbiome of bile correlates with the bacterial composition of saliva, and the microbiome of the biliary tract has a high similarity with the microbiota of the duodenum. Pathogenic microflora of the oral cavity, through mechanisms of immunomodulation, can affect the motility of the gallbladder and the expression of mucin genes (MUC1, Muc3, MUC4), and represent one of the promoters of stone formation in the gallbladder. The presence of H. pylori infection contributes to the formation of gallstones and affects the occurrence of complications of GSD, including acute and chronic cholecystitis, cholangitis, pancreatitis. Intestinal bacteria (Clostridium, Bifidobacterium, Peptostreptococcus, Bacteroides, Eubacterium, and Escherichia coli) participating in the oxidation and epimerization of bile acids can disrupt enterohepatic circulation and lead to the formation of gallstones. At the same time, cholecystectomy due to GSD leads to the further transformation of the composition of the microbiota in various parts of the gastrointestinal tract, increasing the risk of developing stomach cancer and colorectal cancer. Further research is required to determine the possibility of using the evaluation of the composition of the microbiota of the gastrointestinal and biliary tracts as an early diagnostic marker of various gastroenterological diseases.
- 2 June 2020
- Published by MDPI AG in Microorganisms
- Vol. 8 (6) , 835
Open AccessGallstone Disease and Microbiome
Gallstone disease (GSD) has, for many years, remained a high-cost, socially significant public health problem. Over the past decade, a number of studies have been carried out—both in humans and in animal models—confirming the role of the microbiota in various sections of the gastrointestinal tract as a new link in the etiopathogenesis of GSD. The microbiome of bile correlates with the bacterial composition of saliva, and the microbiome of the biliary tract has a high similarity with the microbiota of the duodenum. Pathogenic microflora of the oral cavity, through mechanisms of immunomodulation, can affect the motility of the gallbladder and the expression of mucin genes (MUC1, Muc3, MUC4), and represent one of the promoters of stone formation in the gallbladder. The presence of H. pylori infection contributes to the formation of gallstones and affects the occurrence of complications of GSD, including acute and chronic cholecystitis, cholangitis, pancreatitis. Intestinal bacteria (Clostridium, Bifidobacterium, Peptostreptococcus, Bacteroides, Eubacterium, and Escherichia coli) participating in the oxidation and epimerization of bile acids can disrupt enterohepatic circulation and lead to the formation of gallstones. At the same time, cholecystectomy due to GSD leads to the further transformation of the composition of the microbiota in various parts of the gastrointestinal tract, increasing the risk of developing stomach cancer and colorectal cancer. Further research is required to determine the possibility of using the evaluation of the composition of the microbiota of the gastrointestinal and biliary tracts as an early diagnostic marker of various gastroenterological diseases.
- Open Access
- 8 July 2019
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- No. 6,p. 143-148
Epidemiology and comorbidity of arterial hypertension and gallstone disease
Эпидемиология и коморбидность артериальной гипертензии и желчнокаменной болезни
- 8 July 2019
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- No. 6,p. 143-148
Open AccessEpidemiology and comorbidity of arterial hypertension and gallstone disease
Эпидемиология и коморбидность артериальной гипертензии и желчнокаменной болезни